Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
 
Sponsors and Collaborators
Novartis Pharmaceuticals
 
Contact
Novartis Pharmaceuticals
 
ClinicalTrials.gov Identifier